13F Holdings
中文EN

ECOR electroCore, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1560258 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY27.2%
TTM net income YoY-17.5%
TTM EPS YoY-3.8%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—

Margins

Gross margin86.8%
Operating margin-41.1%
Net margin-43.6%
FCF margin-25.8%
EBITDA margin-39.5%

Returns

ROE-478.7%
ROA-71.4%
ROIC (approx.)-1,217.4%
Asset turnover1.64x

Leverage & solvency

Liabilities / assets109.2%
Debt / equity—
Current ratio1.38x
Interest coverage-882.75x

Cash quality & payout

Operating cash flow / net income0.59x
Accruals ratio-29.5%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$32.03M$25.18M$16.03M$8.59M$5.45M
Cost of revenue$4.24M$3.79M$2.80M$1.62M$1.39M
Gross profit$27.79M$21.40M$13.23M$6.98M$4.07M
R&D expense—$2.36M$5.32M$5.52M$2.54M
SG&A expense$38.21M$31.20M$27.17M$24.33M$21.57M
Operating income-$13.15M-$12.16M-$19.27M-$22.87M-$20.04M
Interest expense$14,900$18,400—$4,000—
Pretax income-$13.96M-$11.98M-$19.02M-$22.59M-$18.07M
Income tax$3,000-$93,000-$186,000-$431,000-$851,000
Net income-$13.97M-$11.89M-$18.83M-$22.16M-$17.22M
EBITDA-$12.65M-$11.40M-$18.31M-$22.33M-$19.66M
EPS (basic)-1.65-1.59-3.42-4.69-4.36
EPS (diluted)-1.65-1.59-3.42-4.69-4.36
Weighted avg. shares (diluted)8,4837,4835.51M4,7293,945
Balance sheet
Cash & equivalents$7.04M$3.70M$10.33M$17.71M$34.69M
Short-term investments$4.58M$8.52M———
Receivables$1.03M$1.37M$717,000$401,000$438,000
Inventory$1.63M$1.68M$2.16M$1.98M$1.36M
Current assets$15.67M$16.30M$14.29M$21.17M$37.54M
PP&E, net$382,000$158,000$204,000$50,000$147,000
Total assets$18.67M$20.47M$16.10M$24.76M$42.83M
Current liabilities$11.35M$9.15M$8.12M$7.04M$5.49M
Long-term debt$6.61M————
Total debt$6.61M————
Total liabilities$20.38M$12.93M$8.66M$7.67M$6.18M
Shareholders' equity-$1.71M$7.54M$7.44M$17.09M$36.65M
Net debt-$428,000————
Shares outstanding8.00M6.65M6.00M4.74M4.71M
Cash flow statement
Operating cash flow-$8.19M-$6.95M-$14.67M-$16.64M-$13.63M
Capital expenditure$66,000—$206,000——
Free cash flow-$8.25M—-$14.87M——
Investing cash flow$3.88M-$8.52M-$206,000—$18.22M
Financing cash flow$7.63M$8.44M$7.49M—$25.68M
Depreciation & amortization$501,000$760,000$962,000$548,000$382,000
Stock-based compensation$1.93M$1.87M$1.70M$2.68M$3.30M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.